The UK government is establishing the AI Biosecurity Lab, backed by £100 million of government funding and up to £200 million in company commitments from OpenAI and Anthropic, the Cabinet Office announced on October 24, 2026.
The announcement said advances in AI are creating unprecedented opportunities for scientific discovery but are also changing the biological risk landscape. It said AI can accelerate research, improve understanding of diseases and support the discovery and development of new medical countermeasures, while increasingly capable AI systems also create new biological risks and could lower barriers to harmful activity.
The government described the AIBL as the world’s first dedicated AI biosecurity organisation, and said the lab builds on the UK’s broader Biological Security Strategy. It characterised the overall package behind the lab as up to £300 million of government funding and company commitments.
Mission and Initial Delivery
According to the announcement, the lab’s mission will be to strengthen biosecurity by harnessing frontier AI. It will bring together frontier AI and biological science talent to develop practical technical capabilities that improve the UK’s ability to understand, prevent, detect and respond to biological threats, and the government said its research will strengthen UK and global resilience to a wide range of biological risks, including those enabled by advances in AI.
Initial delivery will focus on developing and deploying capabilities that enhance early detection of emerging biological threats and accelerate the development of vaccines, treatments and other medical countermeasures. The government said AIBL will harness frontier AI to support partners including the UK’s national biosecurity centres and the country’s life sciences industry, enabling the UK and the world to respond faster to disease outbreaks and strengthening resilience against future biological risks.
Company Commitments and Research Partnerships
The announcement said AIBL will launch with up to £200 million committed from two frontier AI companies. OpenAI will provide £100 million in compute and model credits, together with trusted access to its most capable relevant models through its Rosalind Biodefense programme. Anthropic will provide up to £100 million in model credits, trusted model access and dedicated technical support.
According to the announcement, AIBL will also partner with Google DeepMind and Basecamp Research on research collaborations and AI for science tools. Google DeepMind scientists and biosecurity experts will work with the lab and will look to provide trusted access to frontier Gemini and specialised science models. Basecamp Research, described in the announcement as a pioneering UK AI life sciences company, will provide access to its AI-biology models, capabilities and technical expertise to tackle priority biosecurity challenges.
The government said partnerships will be central to AIBL’s approach. The lab will work with public-sector organisations, academic institutions, industry partners and frontier AI companies in the UK and internationally, and the government intends for it to be supported by both public and philanthropic funding so that additional investment can be channelled towards strengthening biosecurity capabilities over time.
OpenAI launched Rosalind Biodefense on May 29, 2026, as a programme to sponsor trusted developers building defensive applications of AI in the life sciences using GPT-Rosalind, the company’s frontier reasoning model for life sciences research. OpenAI said at the time that the programme supports work across areas such as epidemiological modeling, early detection, screening, preparedness and non-pharmaceutical interventions, and that it was expanding trusted access to GPT-Rosalind for select US government and allied partners with public-health and biodefense missions.
OpenAI named Fourth Eon Biosecurity, Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory and the Coalition for Epidemic Preparedness Innovations among the first organisations it was supporting through the programme.
Independent Structure Within a National Initiative
According to the announcement, AIBL will operate as an independent, non-profit organisation designed to establish the UK as the world leader in AI-enabled biosecurity. The government said that, similar to the AI Security Institute, the lab will attract leading industry and academic technical talent and operate with sufficient autonomy to move with the speed and focus of a frontier AI–bio company.
The lab is being launched as part of a National AI Biosecurity Initiative that brings together the UK Health Security Agency, the Animal and Plant Health Agency and the Defence Science and Technology Laboratory with AIBL and the life sciences sector. The announcement said the lab will maintain strong and trusted partnerships with government agencies and will also work with the Medicines and Healthcare products Regulatory Agency to prepare for health emergencies and inform the regulation of AI-designed medicines.
A scientific advisory committee drawing on expertise from academia, industry and the third sector will support the lab. The government said further details on the scientific advisory committee will be set out in due course.